Revvity and Element Biosciences collaborate to advance sequencing-based IVD neonatal testing
Credit: PeopleImages.com - Yuri A/Shutterstock
This initiative builds upon Revvity's recent introduction of an automated next-generation sequencing (NGS) workflow for newborn sequencing research and strengthens Element’s momentum towards regulatory approval of the benchtop AVITI sequencing system.
Register for FREE to keep reading
Join 12,000+ scientists, engineers, and IT professionals driving innovation through informatics, HPC, and simulation with:
- Insights into HPC, AI, lab informatics & data
- Curated content for life sciences, engineering & academia
- Access to Breakthroughs: real-world computing success
- Free reports & panels, including the Lab Informatics Guide
- White Papers & software updates for smarter research
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
